Travere Therapeutics, Inc. (TVTX)

NASDAQ: TVTX · IEX Real-Time Price · USD

9.80

-0.01 (-0.10%)

At close: Jul 19, 2024, 4:00 PM

10.03

+0.23 (2.35%)

Pre-market: Jul 22, 2024, 7:05 AM EDT

Travere Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2012
Revenue	183.23	145.24	109.46	131.84	198.32	175.34	Upgrade
Revenue Growth (YoY)	28.61%	32.69%	-16.97%	-33.52%	13.11%	6.75%	Upgrade
Cost of Revenue	9.35	11.45	4.42	3.82	6.13	5.23	Upgrade
Gross Profit	173.88	133.79	105.04	128.02	192.2	170.1	Upgrade
Selling, General & Admin	269.65	265.54	197.52	126.28	135.8	128.95	Upgrade
Research & Development	239.17	244.99	227.33	201.16	131.77	140.96	Upgrade
Other Operating Expenses	76.86	11.39	0	0	97.13	7.5	Upgrade
Operating Expenses	585.67	521.93	424.85	327.44	364.7	277.41	Upgrade
Operating Income	-411.8	-388.14	-319.81	-199.43	-172.51	-107.31	Upgrade
Interest Expense / Income	11.35	11.33	11.01	19.68	19.05	18.83	Upgrade
Other Expense / Income	-262.36	-288.3	-52.66	-39.43	-2.77	20.31	Upgrade
Pretax Income	-160.79	-111.18	-278.17	-179.68	-188.79	-146.45	Upgrade
Income Tax	0.34	0.22	0.31	0.41	-19.36	-0.02	Upgrade
Net Income	-161.13	-111.4	-278.48	-180.09	-169.43	-146.43	Upgrade
Shares Outstanding (Basic)	77	74	64	60	48	42	Upgrade
Shares Outstanding (Diluted)	77	74	64	60	48	42	Upgrade
Shares Change	13.15%	16.48%	6.56%	25.86%	12.28%	4.72%	Upgrade
EPS (Basic)	-2.13	-1.50	-4.37	-3.01	-3.56	-3.46	Upgrade
EPS (Diluted)	-2.13	-1.50	-4.37	-3.01	-3.56	-3.46	Upgrade
Free Cash Flow	-338.67	-322.28	-214.85	-38.94	-67.31	-73.78	Upgrade
Free Cash Flow Per Share	-4.39	-4.34	-3.37	-0.65	-1.42	-1.74	Upgrade
Gross Margin	94.90%	92.12%	95.96%	97.10%	96.91%	97.01%	Upgrade
Operating Margin	-224.75%	-267.24%	-292.17%	-151.27%	-86.98%	-61.20%	Upgrade
Profit Margin	-87.94%	-76.70%	-254.41%	-136.60%	-85.43%	-83.51%	Upgrade
Free Cash Flow Margin	-184.84%	-221.90%	-196.28%	-29.54%	-33.94%	-42.08%	Upgrade
EBITDA	-110.58	-61.31	-246.44	-147.25	-145.16	-107.21	Upgrade
EBITDA Margin	-60.35%	-42.21%	-225.14%	-111.69%	-73.19%	-61.15%	Upgrade
Depreciation & Amortization	38.87	38.53	20.72	12.75	24.58	20.41	Upgrade
EBIT	-149.44	-99.84	-267.16	-160	-169.74	-127.62	Upgrade
EBIT Margin	-81.56%	-68.74%	-244.07%	-121.36%	-85.59%	-72.79%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).